An increasing number of people around the world are living with AIDS due to better access to drugs, the United Nations AIDS programme (UNAIDS) has revealed.

In a phone interview with Reuters, UNAIDS director Michel Sidibe said the past 12 months had been a "game-changing year" in the global AIDS fight, as deaths have been averted in poor and middle-income countries.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

"We’ve never had a year when there has been so much science, so much leadership and such results in one year," Sidibe told the news agency.

There are now 31 HIV drugs on the market compared to six at the end of 2004. Major producers include Gilead, Bristol-Myers Squibb, Merck, Pfizer and GlaxoSmithKline.

UNAIDS said in its annual report that 47% of the 14.2 million people eligible for treatment in low and middle-income countries are receiving it, and 2.5 million deaths have been averted in these countries since 1995.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Imagene’s Oncology Intelligence (OI) Suite has won the Innovation Award for Precision Oncology, for transforming how pharma designs and runs oncology trials. From AI-driven biomarker discovery to smarter patient stratification, see how Imagene is cutting time, cost and risk in cancer drug development.

Discover the Impact